Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRWS Holdings Regulatory News (RWS)

Share Price Information for RWS Holdings (RWS)

Share Price is delayed by 15 minutes
Get Live Data
72.20    1.75 (2.48%)
Bid:
71.95
Ask:
72.20
Spread: 0.25 (0.347%)
Market Cap: £267.98m
RWS Live PriceLast checked at - London Stock Exchange

Intraday RWS Holdings Share Chart

Option Exercise, Admission and Total Voting Rights

23 Jan 2025 15:58

RNS Number : 5108U
RWS Holdings PLC
23 January 2025
 

 

23 January 2025

RWS Holdings plc

Option Exercise, Admission and Total Voting Rights

 

RWS Holdings plc ("RWS" or "the Company"), a unique world-leading provider of technology-enabled language, content and intellectual property services, announces that 1,089,666 new ordinary shares of 1p each in the Company ("New Ordinary Shares") were issued today in order to satisfy (i) a share award to an Executive Director in respect of the FY24 bonus and (ii) the exercise of options awarded at nil cost under the Company's Long Term Incentive Plan as part of the Company's FY24 bonus arrangements. RWS has applied to the London Stock Exchange for the admission of 1,089,666 New Ordinary Shares to trading on AIM ("Admission") and Admission is expected to take place at 8:00am on 24 January 2025.

The New Ordinary Shares, when issued, will be fully paid and will rank pari-passu in all respects with the existing ordinary shares, including the right to receive all dividends and other distributions declared, made or paid after the date of issue. The issue and allotment of the New Ordinary Shares will be within the Company's existing authorities.

Total Voting Rights

Subsequent to Admission, there will be 369,807,646 ordinary shares of 1p each in issue with voting rights. No shares are held in treasury. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

 

 

 

About RWS:

RWS is a unique, world-leading provider of technology-enabled language, content and intellectual property services. Through content transformation and multilingual data analysis, our combination of AI-enabled technology and human expertise helps our clients to grow by ensuring they are understood anywhere, in any language.

Our purpose is unlocking global understanding. By combining cultural understanding, client understanding and technical understanding, our services and technology assist our clients to acquire and retain customers, deliver engaging user experiences, maintain compliance and gain actionable insights into their data and content.

Over the past 20 years we've been evolving our own AI solutions as well as helping clients to explore, build and use multilingual AI applications. With 45+ AI-related patents and more than 100 peer-reviewed papers, we have the experience and expertise to support clients on their AI journey.

We work with over 80% of the world's top 100 brands, more than three-quarters of Fortune's 20 'Most Admired Companies' and almost all of the top pharmaceutical companies, investment banks, law firms and patent filers. Our client base spans Europe, Asia Pacific, Africa and North and South America. Our 60+ global locations across five continents service clients in the automotive, chemical, financial, legal, medical, pharmaceutical, technology and telecommunications sectors.

Founded in 1958, RWS is headquartered in the UK and publicly listed on AIM, the London Stock Exchange regulated market (RWS.L). 

For further information, please visit: www.rws.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ALSBUGDBLUDDGUX
Date   Source Headline
23rd Jun 20267:00 amRNSHolding(s) in Company
17th Jun 202611:00 amRNS-RInvestor Presentation via Investor Meet Company
11th Jun 20267:00 amRNSHalf-year Financial Report
2nd Jun 202610:17 amRNSHolding(s) in Company
1st Jun 20267:00 amRNSTotal Voting Rights
5th May 202612:23 pmRNSUpdate re Agreement to acquire Obviously Group Ltd
5th May 20267:00 amRNSAgreement in principle to acquire Obviously Group
1st May 20267:00 amRNSTotal Voting Rights
28th Apr 202612:10 pmRNSHolding(s) in Company
27th Apr 20262:48 pmRNSHolding(s) in Company
23rd Apr 20267:00 amRNSTrading Statement
1st Apr 20267:00 amRNSTotal Voting Rights
26th Mar 20263:41 pmRNSDirector/PDMR Shareholding
25th Mar 20269:15 amRNS-RRWS launches Language Weaver Pro
25th Mar 20267:00 amRNSIssue of Equity and Total Voting Rights
10th Mar 20264:40 pmRNSHolding(s) in Company
10th Mar 20264:40 pmRNSHolding(s) in Company
4th Mar 20269:37 amRNSDirector/PDMR Shareholding
2nd Mar 20267:00 amRNSTotal Voting Rights
12th Feb 202611:45 amRNSDirector/PDMR Shareholding
11th Feb 202611:44 amRNSResult of AGM
11th Feb 20267:00 amRNSAGM Statement
10th Feb 20262:00 pmRNSHolding(s) in Company
6th Feb 202612:30 pmRNSDirector/PDMR Shareholding
2nd Feb 20267:00 amRNSTotal Voting Rights
30th Jan 20263:06 pmRNSHolding(s) in Company
28th Jan 20263:24 pmRNSDirector/PDMR Shareholding
28th Jan 20263:19 pmRNSDirector/PDMR Shareholding
23rd Jan 20261:00 pmRNSDirector/PDMR Shareholding
23rd Jan 20261:00 pmRNSDirector/PDMR Shareholding
23rd Jan 20269:00 amRNSOption Exercise, Admission and Total Voting Rights
23rd Jan 20267:00 amRNSHolding(s) in Company
14th Jan 20267:00 amRNSHolding(s) in Company
8th Jan 20269:00 amRNSPublication of Annual Report and Notice of AGM
2nd Jan 20264:51 pmRNSHolding(s) in Company
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
19th Dec 20257:00 amRNSHolding(s) in Company
19th Dec 20257:00 amRNSHolding(s) in Company
12th Dec 20253:53 pmRNSHolding(s) in Company
11th Dec 20257:01 amRNSDirectorate change
11th Dec 20257:00 amRNSFinal Results
1st Dec 20257:00 amRNSTotal Voting Rights
11th Nov 20258:00 amRNSHolding(s) in Company
7th Nov 20259:00 amRNSHolding(s) in Company
3rd Nov 20257:00 amRNSTotal Voting Rights
31st Oct 20259:00 amRNSHolding(s) in Company
28th Oct 20257:00 amRNSTrading Statement
20th Oct 20253:06 pmRNSHolding(s) in Company
20th Oct 20259:05 amRNS-RHead of Media & Entertainment appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.